portacaval shunt
Recently Published Documents


TOTAL DOCUMENTS

540
(FIVE YEARS 2)

H-INDEX

41
(FIVE YEARS 0)

2021 ◽  
Vol 7 (3) ◽  
pp. e674
Author(s):  
Arielle Cimeno ◽  
Samuel Sultan ◽  
Josue Alvarez-Casas ◽  
Steven I. Hanish ◽  
David A. Bruno ◽  
...  


2019 ◽  
Author(s):  
Chen Guo ◽  
Yumin Zhong ◽  
Qian Wang ◽  
Liwei Hu ◽  
Xiaohong Gu ◽  
...  

Abstract Background :Abernethy malformation is a rare congenital abnormality. Imaging examination is an important method for the diagnosis. The purpose of this study was to demonstrate manifestations of multi-slice computed tomography (MSCT) in Abernethy malformation and its diagnostic accuracy. Methods :Fourteen children with Abernethy malformation were admitted to our center in China between July 2011 and January 2018. All 14 patients (eight males and six females) received MSCT and digital subtraction angiography (DSA) while eight patients also received ultrasound. The patients’ age ranged from 1 to 14 (median age 8 years old). The clinical records of the patients were retrospectively reviewed. MSCT raw data were transferred to an Advantage Windows 4.2 or 4.6 workstation (General Electric Medical Systems, Waukesha, WI). We compared the findings of MSCT with DSA and surgical results in order to ascertain diagnostic accuracy. Results :Three cases had type Ib Abernethy malformation and eleven cases had type II. Two cases of type II Abernethy malformation were misdiagnosed as type Ib using MSCT. Comparing the findings of MSCT with DSA and surgical results, the accuracy of MSCT was 85.7% (12/14), in which 100.0% (3/3) were type Ib and 81.8% (9/11) were type II. Clinical information included congenital heart disease, pulmonary hypertension, diffuse pulmonary arteriovenous fistula, abnormal liver function, hepatic nodules, elevated blood ammonia, and hepatic encephalopathy. Eleven cases were treated after diagnosis. One patient with Abernethy malformation type Ib(1/3) underwent liver transplantation. Seven patients with Abernethy malformation type II (7/11) were treated by shunt occlusion, received laparoscopy, or were treated with open surgical ligation. Another three patients (3/11) with Abernethy malformation type II were treated by interventional portocaval shunt occlusion under DSA. Conclusion :MSCT attains excellent capability in diagnosing type II Abernethy malformation and further shows the location of the portacaval shunt. DSA can help when it is hard to determine diagnosis between Abernethy type Ib and II using MSCT. Key words: Abernethy malformation; Angiography; Tomography



2019 ◽  
Author(s):  
Chen Guo ◽  
Yumin Zhong ◽  
Qian Wang ◽  
Liwei Hu ◽  
Xiaohong Gu ◽  
...  

Abstract Background :Abernethy malformation is a rare congenital abnormality. Imaging examination is an important method for the diagnosis. The purpose of this study was to demonstrate manifestations of multi-slice computed tomography (MSCT) in Abernethy malformation and its diagnostic accuracy. Methods :Fourteen children with Abernethy malformation were admitted to our center in China between July 2011 and January 2018. All 14 patients (eight males and six females) received MSCT and digital subtraction angiography (DSA) while eight patients also received ultrasound. The patients’ age ranged from 1 to 14 (median age 8 years old). The clinical records of the patients were retrospectively reviewed. MSCT raw data were transferred to an Advantage Windows 4.2 or 4.6 workstation (General Electric Medical Systems, Waukesha, WI). We compared the findings of MSCT with DSA and surgical results in order to ascertain diagnostic accuracy. Results :Three cases had type Ib Abernethy malformation and eleven cases had type II. Two cases of type II Abernethy malformation were misdiagnosed as type Ib using MSCT. Comparing the findings of MSCT with DSA and surgical results, the accuracy of MSCT was 85.7% (12/14), in which 100.0% (3/3) were type Ib and 81.8% (9/11) were type II. Clinical information included congenital heart disease, pulmonary hypertension, diffuse pulmonary arteriovenous fistula, abnormal liver function, hepatic nodules, elevated blood ammonia, and hepatic encephalopathy. Eleven cases were treated after diagnosis. One patient with Abernethy malformation type Ib(1/3) underwent liver transplantation. Seven patients with Abernethy malformation type II (7/11) were treated by shunt occlusion, received laparoscopy, or were treated with open surgical ligation. Another three patients (3/11) with Abernethy malformation type II were treated by interventional portocaval shunt occlusion under DSA. Conclusion :MSCT attains excellent capability in diagnosing type II Abernethy malformation and further shows the location of the portacaval shunt. DSA can help when it is hard to determine diagnosis between Abernethy type Ib and II using MSCT. Key words: Abernethy malformation; Angiography; Tomography



2019 ◽  
Author(s):  
Chen Guo ◽  
Yumin Zhong ◽  
Qian Wang ◽  
Liwei Hu ◽  
Xiaohong Gu ◽  
...  

Abstract Background:The purpose of this study was to demonstrate manifestations of multi-slice computed tomography (MSCT) in Abernethy malformation and its diagnostic accuracy. Methods:Fourteen children with Abernethy malformation were admitted to our center in China between July 2011 and January 2018. All 14 patients (eight males and six females) received MSCT and digital subtraction angiography (DSA) while eight patients also received ultrasound. The patients’ age ranged from 1 to 14 (median age 8 years old). The clinical records of the patients were retrospectively reviewed. MSCT raw data were transferred to an Advantage Windows 4.2 or 4.6 workstation (General Electric Medical Systems, Waukesha, WI). We compared the findings of MSCT with DSA and surgical results in order to ascertain diagnostic accuracy. Results:Three cases had type Ib Abernethy malformation and eleven cases had type II. Two cases of type II Abernethy malformation were misdiagnosed as type Ib using MSCT. Clinical information included congenital heart disease, pulmonary hypertension, diffuse pulmonary arteriovenous fistula, abnormal liver function, hepatic nodules, elevated blood ammonia, and hepatic encephalopathy. Comparing the findings of MSCT with DSA and surgical results, the accuracy of MSCT was 85.7% (12/14), in which 100.0% were type Ib and 81.8% were type II. Conclusion:MSCT attains excellent capability in diagnosing type II Abernethy malformation and further shows the location of the portacaval shunt. DSA can help when it is hard to determine diagnosis between Abernethy type Ib and II using MSCT. Key words: Abernethy malformation; Angiograph; Tomography



2019 ◽  
pp. 319-330
Author(s):  
J. J. van Dongen ◽  
J. M. Maessen ◽  
R. J. Oostenbroek ◽  
J. E. G. de Boer ◽  
G. Kootstra ◽  
...  
Keyword(s):  


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Mohammed T. Alsamri ◽  
Mohamed A. Hamdan ◽  
Mohamed Sulaiman ◽  
Hassib Narchi ◽  
Abdul-Kader Souid


2019 ◽  
Vol 133 (1) ◽  
pp. 153-166 ◽  
Author(s):  
John S. Hammond ◽  
Fred Godtliebsen ◽  
Sonja Steigen ◽  
I. Neil Guha ◽  
Judy Wyatt ◽  
...  

Abstract Liver failure is the major cause of death following liver resection. Post-resection portal venous pressure (PVP) predicts liver failure, is implicated in its pathogenesis, and when PVP is reduced, rates of liver dysfunction decrease. The aim of the present study was to characterize the hemodynamic, biochemical, and histological changes induced by 80% hepatectomy in non-cirrhotic pigs and determine if terlipressin or direct portacaval shunting can modulate these effects. Pigs were randomized (n=8/group) to undergo 80% hepatectomy alone (control); terlipressin (2 mg bolus + 0.5–1 mg/h) + 80% hepatectomy; or portacaval shunt (PCS) + 80% hepatectomy, and were maintained under terminal anesthesia for 8 h. The primary outcome was changed in PVP. Secondary outcomes included portal venous flow (PVF), hepatic arterial flow (HAF), and biochemical and histological markers of liver injury. Hepatectomy increased PVP (9.3 ± 0.4 mmHg pre-hepatectomy compared with 13.0 ± 0.8 mmHg post-hepatectomy, P<0.0001) and PVF/g liver (1.2 ± 0.2 compared with 6.0 ± 0.6 ml/min/g, P<0.0001) and decreased HAF (70.8 ± 5.0 compared with 41.8 ± 5.7 ml/min, P=0.002). Terlipressin and PCS reduced PVP (terlipressin = 10.4 ± 0.8 mmHg, P=0.046 and PCS = 8.3 ± 1.2 mmHg, P=0.025) and PVF (control = 869.0 ± 36.1 ml/min compared with terlipressin = 565.6 ± 25.7 ml/min, P<0.0001 and PCS = 488.4 ± 106.4 ml/min, P=0.002) compared with control. Treatment with terlipressin increased HAF (73.2 ± 11.3 ml/min) compared with control (40.3 ± 6.3 ml/min, P=0.026). The results of the present study suggest that terlipressin and PCS may have a role in the prevention and treatment of post-resection liver failure.



Author(s):  
I. I. Zatevakhin ◽  
M. Sh. Tsitsiashvili ◽  
V. N. Shipovskiy ◽  
D. V. Monakhov ◽  
A. S. Chelyapin


HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S435
Author(s):  
E. Khajeh ◽  
M. Golriz ◽  
P. Fathi ◽  
O. Ghamarnejad ◽  
A. Mehrabi


Sign in / Sign up

Export Citation Format

Share Document